# Aerobic Exercise Training Leads to MASH Resolution as Defined by the MASH Resolution Index

**Authors:** Theja Channapragada, Sarah Batra, Breianna L. Hummer, Vernon M. Chinchilli, Daniel Huang, Rohit Loomba, Ian R. Schreibman, Jonathan G. Stine

PMC · DOI: 10.1007/s10620-025-09361-9 · Digestive Diseases and Sciences · 2025-09-03

## TL;DR

Aerobic exercise training helps resolve MASH more effectively than standard care, even without weight loss, according to a new study.

## Contribution

The study shows aerobic exercise improves MASH resolution using the MASH Resolution Index, independent of weight loss.

## Key findings

- Exercise training led to MASH resolution in 33% of participants, compared to 13% in standard care.
- Exercise improved biomarkers like ALT, AST, and MRI-PDFF included in the MASH-RI.

## Abstract

Exercise training is recommended for all patients with metabolic dysfunction-associated steatotic liver disease. Whether exercise training improves liver histology independent of body weight loss remains controversial. Given the increasing reliance on non-invasive biomarkers as a surrogate for liver histology, we investigated the relationship between exercise training and improvement in liver histology using the MASH Resolution Index (MASH-RI), a validated composite score of multiple biomarkers, in a post hoc analysis of the NASHFit trial.

This study randomized adults with biopsy-proven MASH to moderate-intensity aerobic exercise training or standard of care for 20 weeks. Mediterranean-informed dietary counseling was provided to each group. Change in the MASH-RI was measured and compared between the two groups (n = 23).

Applying the MASH-RI, those who performed exercise training achieved MASH resolution nearly three times more often (33% vs. 13%, p < 0.01) versus those who received standard of care. Exercise training improved individual biomarkers included in the MASH-RI, including ALT, AST, and MRI-PDFF.

Exercise training leads to MASH resolution, as defined by the MASH-RI at greater rates than standard lifestyle counseling. Future research is needed to determine how best to use the MASH-RI as a therapeutic monitoring tool to gauge response to lifestyle intervention.

NCT03518294.

## Linked entities

- **Diseases:** MASH (MONDO:0007027), metabolic dysfunction-associated steatotic liver disease (MONDO:0013209)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** metabolic dysfunction (MESH:D008659), weight loss (MESH:D015431), steatotic liver disease (MESH:D008107)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946340/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12946340/full.md

---
Source: https://tomesphere.com/paper/PMC12946340